To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.... [Read More]
Search results for: biosimilars
Drug UPDATES
Information on New Approvals and Medication Safety... [Read More]
Build a Solid Foundation for Patient Care: 2011 Professional Meetings
You’ve come to rely on the ACR for meeting your professional development needs. Along with the ACR/ARHP Annual Scientific Meeting, the College provides symposia and other courses designed especially for rheumatology health professionals.... [Read More]
Drug Updates
Information on New Approvals and Medication Safety... [Read More]
The Good and Bad of Healthcare Reform
Even though the law was passed, the work of reform is just beginning... [Read More]
Drug Safety
What can the ACR do?... [Read More]
- « Previous Page
- 1
- …
- 21
- 22
- 23